Roche Deal Drives DeCode s Q3 Revenues Up 57%

Nov 14, 2000

NEW YORK, Nov 14 – DeCode Genetics’ third quarter revenues surged 57.1 percent, pushed higher by revenues stemming from its collaboration with Roche, the population-genomics company reported Tuesday.

Revenue for the quarter totaled $5.6 million, compared with $3.5 million for the year ago period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

In on the Action

NPR reports that with medical data being big business, some companies want to get patients involved.

What's in Store?

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

This Week in PNAS

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Warren Releases Genetic Ancestry Results

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Main menu